isoflurophate has been researched along with Disease Models, Animal in 39 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (12.82) | 18.7374 |
| 1990's | 6 (15.38) | 18.2507 |
| 2000's | 1 (2.56) | 29.6817 |
| 2010's | 14 (35.90) | 24.3611 |
| 2020's | 13 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bruun, DA; Calsbeek, JJ; Copping, N; Dawson, ME; González, EA; Guignet, MA; Harvey, DJ; Lein, PJ; MacMahon, JA; Saito, NH; Silverman, JL; Yu, AJ | 1 |
| Abreu-Melon, J; Dingledine, R; Rojas, A; Wang, S | 1 |
| Anantharam, V; Gage, M; Gardner, C; Gasser, G; Putra, M; Sharma, S; Thippeswamy, T | 1 |
| Gage, M; Golden, M; Putra, M; Sharma, S; Thippeswamy, T | 1 |
| Dingledine, R; Glover, A; Rojas, A; Wang, J | 1 |
| Auvin, S; Dal Bo, G; Dupuis, N; Enderlin, J; Igert, A; Nachon, F | 1 |
| Ashbrook, DG; Gao, J; Jones, BC; Lu, L; Miller, DB; O'Callaghan, JP; Starlard-Davenport, A; Williams, RW; Xu, F; Zhao, W | 1 |
| Bealer, SL; Dudek, FE; Smolik, M; Spampanato, J | 1 |
| Hester, K; Liu, J; Pope, C | 1 |
| Abreu-Melon, J; Dingledine, R; McCarren, HS; McDonough, JH; Rojas, A; Wang, J; Wang, S; Wang, W | 1 |
| Calderazzo, S; Kelly, KA; Killiany, RJ; Koo, BB; Michalovicz, LT; O'Callaghan, JP; Sullivan, K | 1 |
| Garbow, JR; Harvey, DJ; Hobson, BA; Lein, PJ; Rowland, DJ; Supasai, S | 1 |
| Day, BJ; Huang, J; Liang, LP; McElroy, P; Patel, M; Pearson-Smith, JN | 1 |
| Dingledine, R; Ganesh, T; Rojas, A; Wang, J; Wang, W | 1 |
| Bruun, DA; Guignet, M; Harvey, DJ; Lein, PJ | 1 |
| Blair, RE; Deshpande, LS; Phillips, KF; Santos, E | 1 |
| Bruun, DA; Dhakal, K; Dhir, A; Flannery, BM; Guignet, M; Harvey, DJ; Hobson, BA; Lein, PJ; Li, S; Rogawski, MA; Silverman, JL; Wahab, A; Zolkowska, D | 1 |
| Anantharam, V; Gage, M; Gasser, G; Gregory-Flores, A; Hinojo-Perez, A; Olson, A; Putra, M; Puttachary, S; Sharma, S; Thippeswamy, T; Wang, C | 1 |
| Bealer, SL; Dudek, FE; Pouliot, W; Roach, B; Spampanato, J | 1 |
| Dingledine, R; Ganesh, T; Gueorguieva, P; Lelutiu, N; Rojas, A | 1 |
| Kelly, KA; Lasley, SM; Locker, AR; Miller, DB; O'Callaghan, JP | 1 |
| Bruun, DA; Distel, TJ; Ford, BD; Ford, GD; Gates, AS; Lein, PJ; Li, Y; Liu, C; Stovall, KC; Surles-Zeigler, MC; Tewolde, T; White, TE | 1 |
| Deshpande, LS; Phillips, KF | 1 |
| Bruun, DA; Hammock, BD; Lein, PJ; Pessah, IN; Rogawski, MA; Tancredi, DJ; Wulff, H; Zolkowska, D | 1 |
| Dingledine, R; Ganesh, T; Manji, Z; O'neill, T; Rojas, A | 1 |
| Aschner, M; Gupta, RC; Milatovic, D; Zaja-Milatovic, S | 1 |
| Dori, A; Duek, O; Kofman, O; Lin, T; Livneh, U; Oriel, S | 1 |
| Auta, J; Davis, JM; Gocel, J; Guidotti, A; Kadriu, B; Larson, J; Nambiar, MP | 1 |
| Bito, LZ; Bunke, A | 1 |
| Wickelgren, I | 1 |
| Buccafusco, JJ; Zhang, LC | 1 |
| Albuquerque, EX; Copio, DS; Eldefrawi, AT; Eldefrawi, ME; Oliveira, AC | 1 |
| Carboni, D; Dyer, K; Ehrich, M; Jortner, BS | 1 |
| Dyer, KR; Ehrich, M; Jortner, BS; Shell, LG | 1 |
| Overstreet, DH; Pucilowski, O; Schiller, GD; Wienicke, C | 1 |
| Aulerich, RJ; Bursian, SJ; Lehning, EJ; Tanaka, D | 1 |
| Overstreet, DH | 1 |
| Baker, WW; Lalley, PM; Rossi, GV | 1 |
| Bronson, LJ; Lazar, M | 1 |
3 review(s) available for isoflurophate and Disease Models, Animal
| Article | Year |
|---|---|
A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition.
Topics: Animals; Cholinesterase Inhibitors; Disease Models, Animal; Indoles; Isoflurophate; Organophosphate Poisoning; Rats; Receptors, Prostaglandin E, EP2 Subtype; Status Epilepticus | 2020 |
Persistent behavior deficits, neuroinflammation, and oxidative stress in a rat model of acute organophosphate intoxication.
Topics: Animals; Behavior, Animal; Brain; Disease Models, Animal; Inflammation; Isoflurophate; Male; Neurotoxicity Syndromes; Organophosphate Poisoning; Oxidative Stress; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2020 |
Models to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agents.
Topics: Animals; Anticonvulsants; Brain; Bridged-Ring Compounds; Cholinesterase Inhibitors; Disease Models, Animal; Humans; Isoflurophate; Neuroprotective Agents; Organophosphate Poisoning; Seizures; Treatment Outcome | 2016 |
36 other study(ies) available for isoflurophate and Disease Models, Animal
| Article | Year |
|---|---|
Persistent neuropathology and behavioral deficits in a mouse model of status epilepticus induced by acute intoxication with diisopropylfluorophosphate.
Topics: Acetylcholinesterase; Animals; Brain; Cholinesterase Inhibitors; Disease Models, Animal; Electroencephalography; Female; Isoflurophate; Male; Mice; Mice, Inbred C57BL; Nesting Behavior; Neuroinflammatory Diseases; Open Field Test; Status Epilepticus | 2021 |
Time-dependent neuropathology in rats following organophosphate-induced status epilepticus.
Topics: Animals; Brain; Disease Models, Animal; Isoflurophate; Organophosphate Poisoning; Organophosphates; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2022 |
Diapocynin, an NADPH oxidase inhibitor, counteracts diisopropylfluorophosphate-induced long-term neurotoxicity in the rat model.
Topics: Acetophenones; Animals; Biphenyl Compounds; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Hippocampus; Isoflurophate; Male; NADPH Oxidases; Nerve Agents; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2020 |
Sex as a biological variable in the rat model of diisopropylfluorophosphate-induced long-term neurotoxicity.
Topics: Animals; Brain; Disease Models, Animal; Female; Isoflurophate; Male; Neurotoxicity Syndromes; Rats; Sex Characteristics; Status Epilepticus | 2020 |
Urethane attenuates early neuropathology of diisopropylfluorophosphate-induced status epilepticus in rats.
Topics: Acetylcholinesterase; Animals; Brain Injuries; Diazepam; Disease Models, Animal; Electroencephalography; Enzyme Inhibitors; Hippocampus; Isoflurophate; Male; Rats; Rats, Sprague-Dawley; Seizures; Status Epilepticus; Urethane | 2020 |
Characterization of organophosphate-induced brain injuries in a convulsive mouse model of diisopropylfluorophosphate exposure.
Topics: Animals; Brain; Brain Injuries; Cholinesterase Inhibitors; Disease Models, Animal; Electrocorticography; Isoflurophate; Male; Mice; Organophosphates; Seizures; Status Epilepticus | 2020 |
Genome-wide transcriptome architecture in a mouse model of Gulf War Illness.
Topics: Animals; Disease Models, Animal; GTP-Binding Protein alpha Subunits, Gi-Go; Gulf War; Isoflurophate; Mice; Persian Gulf Syndrome; Transcriptome | 2020 |
Delayed Adjunctive Treatment of Organophosphate-Induced Status Epilepticus in Rats with Phenobarbital, Memantine, or Dexmedetomidine.
Topics: Animals; Anticonvulsants; Brain; Cell Death; Dexmedetomidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Isoflurophate; Male; Memantine; Neurons; Phenobarbital; Prohibitins; Rats; Rats, Sprague-Dawley; Status Epilepticus; Time-to-Treatment; Treatment Outcome | 2020 |
Dose- and time-related effects of acute diisopropylfluorophosphate intoxication on forced swim behavior and sucrose preference in rats.
Topics: Anhedonia; Animals; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Isoflurophate; Male; Rats; Rats, Sprague-Dawley; Sucrose; Swimming | 2021 |
Comparison of neuropathology in rats following status epilepticus induced by diisopropylfluorophosphate and soman.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Waves; Cell Death; Cyclooxygenase 2; Disease Models, Animal; Electroencephalography; Encephalitis; Gliosis; Isoflurophate; Male; Rats, Sprague-Dawley; Soman; Status Epilepticus; Time Factors; Weight Loss | 2021 |
Corticosterone potentiates DFP-induced neuroinflammation and affects high-order diffusion imaging in a rat model of Gulf War Illness.
Topics: Animals; Brain; Corticosterone; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Encephalitis; Isoflurophate; Male; Persian Gulf Syndrome; Rats, Sprague-Dawley; Stress, Physiological | 2018 |
A magnetic resonance imaging study of early brain injury in a rat model of acute DFP intoxication.
Topics: Animals; Brain Injuries; Disease Models, Animal; Isoflurophate; Magnetic Resonance Imaging; Male; Rats, Sprague-Dawley; Status Epilepticus | 2018 |
Neuroprotective Effects of AEOL10150 in a Rat Organophosphate Model.
Topics: Animals; Antioxidants; Disease Models, Animal; Isoflurophate; Male; Metalloporphyrins; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Rats, Sprague-Dawley | 2018 |
Pretreatment with pyridostigmine bromide has no effect on seizure behavior or 24 hour survival in the rat model of acute diisopropylfluorophosphate intoxication.
Topics: Acetylcholinesterase; Animals; Brain; Cholinesterase Inhibitors; Disease Models, Animal; GPI-Linked Proteins; Isoflurophate; Male; Neurotoxicity Syndromes; Organophosphate Poisoning; Pyridostigmine Bromide; Rats, Sprague-Dawley; Seizures; Time Factors | 2019 |
Targeting Intracellular Calcium Stores Alleviates Neurological Morbidities in a DFP-Based Rat Model of Gulf War Illness.
Topics: Animals; Calcium; Disease Models, Animal; Hippocampus; Isoflurophate; Levetiracetam; Male; Maze Learning; Persian Gulf Syndrome; Rats; Rats, Sprague-Dawley | 2019 |
Inducible nitric oxide synthase inhibitor, 1400W, mitigates DFP-induced long-term neurotoxicity in the rat model.
Topics: Amidines; Animals; Benzylamines; Brain; Disease Models, Animal; Enzyme Inhibitors; Isoflurophate; Male; Nerve Agents; Nerve Degeneration; Neuroprotective Agents; Neurotoxicity Syndromes; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley | 2020 |
Antiseizure and neuroprotective effects of delayed treatment with midazolam in a rodent model of organophosphate exposure.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Isoflurophate; Male; Midazolam; Neuroprotective Agents; Organophosphate Poisoning; Rats; Rats, Sprague-Dawley; Seizures | 2019 |
Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus.
Topics: Acetylcholinesterase; Animals; Behavior, Animal; Body Weight; Chemokines; Cholinesterase Inhibitors; Cyclooxygenase 2; Disease Models, Animal; Gliosis; Hippocampus; Indoles; Isoflurophate; Male; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E, EP2 Subtype; Recovery of Function; Status Epilepticus; Time Factors | 2015 |
Corticosterone primes the neuroinflammatory response to DFP in mice: potential animal model of Gulf War Illness.
Topics: Animals; Anti-Inflammatory Agents; Chemical Warfare Agents; Cholinesterase Inhibitors; Corticosterone; DEET; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Insect Repellents; Isoflurophate; Male; Mice; Mice, Inbred C57BL; Minocycline; Persian Gulf Syndrome | 2015 |
Neuregulin-1 inhibits neuroinflammatory responses in a rat model of organophosphate-nerve agent-induced delayed neuronal injury.
Topics: Animals; Brain; Cholinesterase Inhibitors; Cytokines; Disease Models, Animal; Encephalitis; Gene Expression Profiling; Gene Expression Regulation; Injections, Intra-Arterial; Isoflurophate; Male; Microglia; Neuregulin-1; Neuroprotective Agents; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2015 |
Repeated low-dose organophosphate DFP exposure leads to the development of depression and cognitive impairment in a rat model of Gulf War Illness.
Topics: Anhedonia; Animals; Anxiety; Depression; Disease Models, Animal; Hippocampus; Isoflurophate; Male; Memory Disorders; Organophosphates; Persian Gulf Syndrome; Rats | 2016 |
Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats.
Topics: Animals; Anxiety; Brain; Discrimination, Psychological; Disease Models, Animal; Electroencephalography; Exploratory Behavior; Indoles; Isoflurophate; Male; Memory Disorders; Nootropic Agents; Random Allocation; Rats, Sprague-Dawley; Receptors, Prostaglandin E, EP2 Subtype; Recognition, Psychology; Status Epilepticus | 2016 |
Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist.
Topics: Animals; Antioxidants; Biomarkers; Brain; Cholinesterase Inhibitors; Cyclic N-Oxides; Disease Models, Animal; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Isoflurophate; Lipid Peroxidation; Male; Memantine; Neurodegenerative Diseases; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Seizures; Time Factors; Vitamin A | 2009 |
Acetylcholinesterase inhibitor pretreatment alters stress-induced expression of acetylcholinesterase transcripts in the mouse brain.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Brain; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gene Expression Regulation, Enzymologic; Isoflurophate; Maze Learning; Mice; Mice, Inbred C57BL; Reaction Time; RNA, Messenger; Species Specificity; Statistics as Topic; Stress, Psychological | 2011 |
Absence of tolerance to the anticonvulsant and neuroprotective effects of imidazenil against DFP-induced seizure and neuronal damage.
Topics: Animals; Anticonvulsants; Benzodiazepines; Cholinesterase Inhibitors; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoresceins; Imidazoles; Isoflurophate; Male; Neurons; Neuroprotective Agents; Organic Chemicals; Rats; Rats, Inbred F344; Seizures; Statistics, Nonparametric | 2011 |
Gradual increase in the sensitivity of extraocular muscles to acetylcholine during topical treatment of rabbit eyes with isoflurophate.
Topics: Acetylcholine; Animals; Disease Models, Animal; Drug Synergism; Esotropia; Eye Diseases; Glaucoma; Isoflurophate; Oculomotor Muscles; Rabbits | 1981 |
Rat model for Gulf War syndrome?
Topics: Animals; Disease Models, Animal; Hippocampus; Humans; Isoflurophate; Maze Learning; Military Personnel; Nicotinic Antagonists; Persian Gulf Syndrome; Rats; Receptors, Nicotinic | 1997 |
Prevention of morphine-induced muscarinic (M2) receptor adaptation suppresses the expression of withdrawal symptoms.
Topics: Animals; Behavior, Animal; Blood Pressure; Body Weight; Disease Models, Animal; Infusions, Intravenous; Injections, Subcutaneous; Isoflurophate; Male; Morphine; Morphine Dependence; Naloxone; Pirenzepine; Rats; Rats, Wistar; Receptor, Muscarinic M2; Receptors, Muscarinic; Substance Withdrawal Syndrome; Vasomotor System | 1998 |
Myasthenia gravis animal model: quantitative analysis of the efficiency of pre- and postjunctional regions of intercostal muscles in rabbits immunized with Torpedo acetylcholine receptor.
Topics: Acetylcholine; Action Potentials; Animals; Disease Models, Animal; Electric Organ; Isoflurophate; Motor Endplate; Myasthenia Gravis; Neuromuscular Junction; Rabbits; Receptors, Cholinergic; Synaptic Transmission | 1979 |
Comparative evolution of mipafox-induced delayed neuropathy in rats and hens.
Topics: Animals; Carboxylic Ester Hydrolases; Chickens; Disease Models, Animal; Female; Isoflurophate; Male; Nervous System Diseases; Rats; Species Specificity | 1992 |
Comparative dose-response studies of organophosphorus ester-induced delayed neuropathy in rats and hens administered mipafox.
Topics: Animals; Carboxylic Ester Hydrolases; Chickens; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Isoflurophate; Male; Microscopy, Electron; Nervous System Diseases; Rats; Species Specificity | 1992 |
Immobility-reducing effects of antidepressants in a genetic animal model of depression.
Topics: Animals; Antidepressive Agents; Depression; Depression, Chemical; Desipramine; Disease Models, Animal; Imipramine; Isoflurophate; Motor Activity; Rats; Rats, Inbred Strains; Swimming | 1992 |
Delayed neurotoxic effects of bis (1-methylethyl) phosphorofluoridate (DFP) in the European ferret: a possible mammalian model for organophosphorus-induced delayed neurotoxicity.
Topics: Animals; Carboxylic Ester Hydrolases; Central Nervous System; Cerebellum; Cholinesterases; Disease Models, Animal; Female; Ferrets; Isoflurophate; Male; Medulla Oblongata; Organophosphorus Compounds; Silver Staining; Spinal Cord; Time Factors | 1991 |
Selective breeding for increased cholinergic function: development of a new animal model of depression.
Topics: Animals; Arecoline; Breeding; Depression; Depressive Disorder; Disease Models, Animal; Electroshock; Isoflurophate; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Stress, Physiological | 1986 |
Analysis of local cholinergic tremor mechanisms following selective neurochemical lesions.
Topics: Acetylcholine; Animals; Basal Ganglia; Brain; Carbachol; Cats; Cholinesterase Inhibitors; Disease Models, Animal; Dopamine; Drug Antagonism; Drug Synergism; Epinephrine; Hemicholinium 3; Isoflurophate; Ketones; Male; Oximes; Pentobarbital; Physostigmine; Pralidoxime Compounds; Receptors, Drug; Scopolamine; Tremor | 1970 |
The role of corneal exposure in cataract formation in DFP-treated guinea pigs.
Topics: Animals; Cataract; Corneal Opacity; Disease Models, Animal; Guinea Pigs; Isoflurophate; Lens, Crystalline | 1970 |